Effect of Everolimus-Eluting Stents in Different Vessel Sizes (from the Pooled FUTURE I and II Trials)
Open Access
- 15 August 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (4) , 464-469
- https://doi.org/10.1016/j.amjcard.2006.02.054
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)The American Journal of Cardiology, 2005
- Six- and Twelve-Month Results From First Human Experience Using Everolimus-Eluting Stents With Bioabsorbable PolymerCirculation, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL)Circulation, 2002
- Stent Placement Compared With Balloon Angioplasty for Small Coronary ArteriesCirculation, 2001
- A Randomized Trial Comparing Stenting With Balloon Angioplasty in Small Vessels in Patients With Symptomatic Coronary Artery DiseaseCirculation, 2000
- SDZ RAD, A NEW RAPAMYCIN DERIVATIVETransplantation, 1997
- Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomyJournal of the American College of Cardiology, 1993